Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John P Lahad

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|May 21, 2004
Analysis of molecular aberrations in ovarian cancer allows novel target identificationKwai Wa Cheng, John P Lahad, Gordon B Mills
The Journal of Clinical Investigation|June 3, 2005
Stem cell-ness: a "magic marker" for cancerJohn P Lahad, Gordon B Mills, Kevin R Coombes
Cancer Research|April 5, 2005
Emerging role of RAB GTPases in cancer and human diseaseKwai W Cheng, John P Lahad, Joseph W Gray, et al.
Cancer Cell|July 29, 2006
BRIT1 regulates early DNA damage response, chromosomal integrity, and cancerRekha Rai, Hui Dai, Asha S Multani, et al.
Nature Medicine|October 27, 2004
The RAB25 small GTPase determines aggressiveness of ovarian and breast cancersKwai Wa Cheng, John P Lahad, Wen-Lin Kuo, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 24, 2005
Atypical PKCiota contributes to poor prognosis through loss of apical-basal polarity and cyclin E overexpression in ovarian cancerAstrid M Eder, Xiaomei Sui, Daniel G Rosen, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|May 21, 2004
Analysis of molecular aberrations in ovarian cancer allows novel target identificationKwai Wa Cheng, John P Lahad, Gordon B Mills
The Journal of Clinical Investigation|June 3, 2005
Stem cell-ness: a "magic marker" for cancerJohn P Lahad, Gordon B Mills, Kevin R Coombes
Cancer Research|April 5, 2005
Emerging role of RAB GTPases in cancer and human diseaseKwai W Cheng, John P Lahad, Joseph W Gray, et al.
Cancer Cell|July 29, 2006
BRIT1 regulates early DNA damage response, chromosomal integrity, and cancerRekha Rai, Hui Dai, Asha S Multani, et al.
Nature Medicine|October 27, 2004
The RAB25 small GTPase determines aggressiveness of ovarian and breast cancersKwai Wa Cheng, John P Lahad, Wen-Lin Kuo, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 24, 2005
Atypical PKCiota contributes to poor prognosis through loss of apical-basal polarity and cyclin E overexpression in ovarian cancerAstrid M Eder, Xiaomei Sui, Daniel G Rosen, et al.
Pageof 1